BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/24/2021 2:07:00 AM | Browse: 362 | Download: 802
 |
Received |
|
2021-02-19 11:45 |
|
Peer-Review Started |
|
2021-02-19 11:51 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-25 04:21 |
|
Revised |
|
2021-04-06 19:26 |
|
Second Decision |
|
2021-07-14 03:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-14 05:52 |
|
Articles in Press |
|
2021-07-14 05:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-19 05:51 |
|
Typeset the Manuscript |
|
2021-08-17 02:21 |
|
Publish the Manuscript Online |
|
2021-08-24 02:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Christina Große-Thie, Claudia Maletzki, Christian Junghanss and Kathie Schmidt |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kathie Schmidt, MD, Medical Assistant, Department of Medicine, Clinic III - Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, Ernst-Heydemann-Str. 6, Rostock 18057, Germany. kathie.schmidt@med.uni-rostock.de |
| Key Words |
Squamous cell carcinoma of the head and neck; Cancer of unknown primary; Long-term survival; Cetuximab; Metastases; Case report |
| Core Tip |
A 42-year-old female patient suffered from metastatic squamous-cell head and neck cancer with occult primary with lymph node and bone metastases. She received palliative immune-chemotherapy with cetuximab, 5-fluorouracil, and platinum as first-line treatment and subsequent irradiation of further abdominal lymph node and bone metastases. Although survival rates are very poor in this setting the patient is still alive 10 years after treatment and in complete remission. Here, we present a rare case of long-term survival despite poor prognosis after palliative immunotherapy even before the era of immune checkpoint inhibitors. |
| Publish Date |
2021-08-24 02:07 |
| Citation |
Große-Thie C, Maletzki C, Junghanss C, Schmidt K. Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report. World J Clin Cases 2021; 9(24): 7092-7098 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i24/7092.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i24.7092 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
